MktsMarkets

Edwards Lifesciences Corporation
NYSE: EWKey statistics
EW News
Stories mentioning EW from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,648,600 | 1,569,600 | 1,553,100 | 1,532,200 | 1,412,700 | 1,385,800 | 1,354,400 | 1,369,400 |
| Cost of Goods Sold | 362,600 | 343,000 | 345,200 | 344,400 | 301,600 | 292,200 | 262,900 | 275,500 |
| Gross Profit | 1,286,000 | 1,226,600 | 1,207,900 | 1,187,800 | 1,111,100 | 1,093,600 | 1,091,500 | 1,093,900 |
| Operating Expenses | ||||||||
| Research & Development | 263,300 | 267,700 | 280,700 | 276,200 | 254,600 | 271,100 | 253,400 | 271,800 |
| Sales General & Admin | 522,200 | 602,900 | 514,600 | 502,000 | 465,700 | 491,900 | 421,400 | 447,500 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 477,600 | 151,100 | 307,100 | 411,200 | 394,800 | 312,600 | 350,600 | 366,500 |
| Interest Income | 33,500 | 36,500 | ||||||
| Interest Expense | ||||||||
| Other Expense | 71,500 | 3,200 | 2,700 | (1,300) | 2,600 | 33,300 | 27,900 | 2,000 |
| Pretax Income | 459,000 | 90,400 | 348,400 | 400,200 | 433,900 | 390,100 | 402,800 | 384,000 |
| Tax Provision | 78,300 | 26,200 | 56,100 | 64,300 | 70,300 | 45,100 | 40,700 | 20,000 |
| Net Income (Loss) | 380,700 | 91,200 | 291,100 | 333,200 | 358,000 | 385,600 | 3,070,800 | 366,300 |
| Earnings Per Share (Basic) | 0.66 | 0.16 | 0.50 | 0.57 | 0.61 | 0.65 | 5.14 | 0.61 |
| Earnings Per Share (Diluted) | 0.66 | 0.16 | 0.50 | 0.56 | 0.61 | 0.65 | 5.13 | 0.61 |
| Weighted Average Shares Outstanding (Basic) | 579,200 | 584,800 | 584,700 | 587,000 | 586,900 | 597,700 | 597,200 | 602,100 |
| Weighted Average Shares Outstanding (Diluted) | 580,700 | 585,800 | 585,700 | 587,900 | 587,800 | 599,300 | 598,100 | 604,300 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About EW
Edwards Lifesciences Corporation (NYSE: EW) is a stock listed on the New York Stock Exchange under the ticker symbol EW. It last traded at $102.14 (Nov 6, 2026, 4:00 PM ET), up 1.3% on the day. That gives Edwards Lifesciences a market capitalisation of $58.9B and a price-to-earnings ratio of 58.6.
Over the past 52 weeks EW has traded between $74.66 and $104.17.
Revenue for the quarter ended Mar 31, 2026 was $1.6B; net income $380.7M. Revenue was up 16.7% from $1.4B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.6B | $380.7M | 23.1% |
| Dec 31, 2025 | $1.6B | $91.2M | 5.8% |
| Sep 30, 2025 | $1.6B | $291.1M | 18.7% |
| Jun 30, 2025 | $1.5B | $333.2M | 21.7% |
From Edwards Lifesciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…